SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DUSA (DUSA) Pharmaceutical
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TulipMania who wrote (32)5/29/1998 11:45:00 AM
From: Ron Harvey  Read Replies (1) of 101
 
Mike,

The stock's treated me well, also, and I'm a tad surprised to find myself in it again because of news that seems to do little more than take Dusa back to around where they were vis a vis a partnership in February. ( They traded from 10 3/4 to 12 7/8 then.) Except that now they've got three more months of research under their belts. The stock could even slip to the 6's for a while, but the next several months could see a 50% rise from where they are now.

From a couple of posts back: "Hopefully Dusa's management will learn from this experience and. . . negotiate more realistically. . . ."

This is an assumption that Dusa is at fault, despite the announcement declaring that changes at the proposed partner's parent company were what caused the deal to fall through. One could just as easily assume that the announcement is true. I doubt that any of us here has inside information about the details.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News